Biophotonics Inc was in the business of developing and marketing medical instruments that use light as a means to detect tissue abnormalities such as cancer. In June 1997, for a combination of cash and common stock, substantially all the assets of BioPhotonics Corporation were acquired by Genomic Solutions (Nasdaq- GNSL) with the principals of the firm having moved on to other ventures
